3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

Completed · Phase 4 · Has a placebo group

Conditions studied: Prostate Cancer

In brief

The investigators will propose a novel method to improve prostate cancer screening with PSA, using a 3-month treatment with finasteride, a drug used to treat Benign Prostatic Hyperplasia (BPH) and proven to reduce a man's risk of developing prostate cancer. The investigators will also examine three additional promising tests that may further improve diagnosis of prostate cancer.

Key facts

Study ID
NCT01296672
Run by
The University of Texas Health Science Center at San Antonio
People needed
383
Starts
2011-02-01
Expected to finish
2017-01-01
Last updated by the study team
2017-10-06

Who can join

Age: 55 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.